A Multicenter, Open-Label, Randomized, 24-Week Study to Compare the Safety and Activity of Indinavir Sulfate, 800 Mg q 8 h Versus 1,200 Mg q 12 h in Combination With Zidovudine and 3TC

Pittsburgh Treatment Ctr / Univ of Pittsburgh, Pittsburgh

Allegheny Univ Hosp, Philadelphia

Wilmington Hosp / Med Ctr of Delaware, Wilmington

Georgetown Univ Med Ctr, Washington D.C.

Johns Hopkins Hosp, Baltimore

AIDS Research Consortium of Atlanta, Atlanta

Cook County Hosp, Chicago

Washington Univ, St Louis

LAC/USC Med Ctr, Los Angeles

Kaiser Med Ctr, San Francisco

Univ of Washington / AIDS Clinical Trial Unit, Seattle

Univ Hosp / SUNY at Stony Brook / AIDS TMT Unit, Stony Brook

Univ of Alabama at Birmingham, Birmingham

Vanderbilt Univ Med Ctr, Nashville

Brown Univ / Miriam Hosp, Providence